|
|
||
|---|---|---|
| Moderator 主持人 | David J. Moliterno, Roxana Mehran, Elvin Kedhi, Shuyang Zhang 张抒扬 | |
|
8:30 AM- |
ACC/AHA vs. ESC Guidelines on Dual Antiplatelet Therapy ACC/AHA与ESC针对双联抗血小板治疗的指南比较 |
Dominick J. Angiolillo |
|
8:42 AM- |
Current Status of DAPT for Coronary DES in US 美国对于DAPT在冠脉药物洗脱支架研究现状 |
Roxana Mehran |
|
8:52 AM- |
Current Status of DAPT for Coronary DES in China 中国对于DAPT在冠脉药物洗脱支架的研究现状 |
Yaling Han 韩雅玲 |
|
9:02 AM- |
Current Status of DAPT for Coronary DES in Singapore 新加坡对于DAPT在冠脉药物洗脱支架研究现状 |
Chee Tang Chin |
|
9:10 AM- |
Clinical Implications of the GLOBAL LEADERS Trial GLOBAL LEADERS试验的临床意义 |
Patrick W. Serruys |
|
9:18 AM- |
Clinical Implications of the REDUCE Trial REDUCE试验的临床意义 |
Harry Suryapranata |
|
9:26 AM- |
Clinical Implications of the LEADERS FREE Trials LEADERS FREE系列试验的临床意义 |
Mitchell W. Krucoff |
|
9:34 AM- |
Clinical Implications of the DAPT-STEMI Trial DAPT-STEMI试验的临床意义 |
Elvin Kedhi |
|
9:42 AM- |
Clinical Implications of the STOPDAPT 2 Trial STOPDAPT 2试验的临床意义 |
Renu Virmani |
|
9:50 AM- |
Panel Discussion 专家讨论 |
|
|
|
||
|---|---|---|
| Moderator 主持人 | Marie-Claude Morice, Zuyi Yuan 袁祖贻, Harry Suryapranata, Joo-Young Yang | |
|
10:00 AM- |
Optimal DAPT Duration after PCI in 2019 2019年PCI术后DAPT时长优化 |
Roxana Mehran |
|
10:10 AM- |
Individualized Antiplatelet Therapy Guided by Risk Scores 风险评分指导的个体化抗血小板治疗 |
Jinqing Yuan 袁晋青 |
|
10:20 AM- |
DAPT Post-Stenting: Where We Are Heading? 支架置入后的DAPT-我们的方向是？ |
Rohit Mathur |
|
10:30 AM- |
Ticagrelor Monotherapy: Platelet Function Assessment in the TEMPLATE Randomized Trial 替格瑞洛单药治疗：TEMPLATE随机试验中的血小板功能评估 |
Andreas Baumbach |
|
10:40 AM- |
DAPT vs. Monotherapy after PCI PCI术后双联抗血小板治疗和单药治疗对比 |
Ruqiong Nie 聂如琼 |
|
10:50 AM- |
DAPT and PCI, When Should the Divorce Start? DAPT与PCI，该何时将其分开？ |
Pieter C. Smits |
|
11:00 AM- |
Panel Discussion 专家讨论 |
|
|
|
||
|---|---|---|
| Moderator 主持人 | Ruiyan Zhang 张瑞岩, Chuen-Den Tseng, Heng-Chia Chang, Yingxin Zhao 赵迎新 | |
|
11:06 AM- |
Practical Considerations for Long DAPT Based on Lesion and Patient Selections 基于病变类型和患者选择而进行长期DAPT的实践考量 |
Tullio Palmerini |
|
11:14 AM- |
DAPT in Elderly Patients 高龄患者DAPT的应用 |
Vincent On-Hing Kwok |
|
11:22 AM- |
Complexity of DAPT for ACS with HBR after PCI ACS合并高出血风险患者PCI术后双抗的复杂性 |
Xiling Shou 寿锡凌 |
|
11:30 AM- |
Strategy to Reduce Bleeding Risk of DAPT in ACS Patients 降低ACS患者DAPT出血风险的策略 |
Zhuhua Yao 姚朱华 |
|
11:38 AM- |
Right PCI Timing for STEMI Patients with Intracerebral Hemorrhage STEMI合并脑出血患者PCI的时机选择 |
Zhilin Miao 苗志林 |
|
11:46 AM- |
Flexibility of DAPT Duration in High Bleeding Risk Patients 在高出血风险患者中DAPT时长的灵活性 |
Po-Lin Lin |
|
11:54 AM- |
Panel Discussion 专家讨论 |
|
|
12:00 PM- |
Adjourn 休会 |
|